Cargando…
A locked immunometabolic switch underlies TREM2 R47H loss of function in human iPSC‐derived microglia
Loss‐of‐function genetic variants of triggering receptor expressed on myeloid cells 2 (TREM2) are linked with an enhanced risk of developing dementias. Microglia, the resident immune cell of the brain, express TREM2, and microglial responses are implicated in dementia pathways. In a normal surveilla...
Autores principales: | Piers, Thomas M., Cosker, Katharina, Mallach, Anna, Johnson, Gabriel Thomas, Guerreiro, Rita, Hardy, John, Pocock, Jennifer M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027848/ https://www.ncbi.nlm.nih.gov/pubmed/31907987 http://dx.doi.org/10.1096/fj.201902447R |
Ejemplares similares
-
Microglial signalling pathway deficits associated with the patient derived R47H TREM2 variants linked to AD indicate inability to activate inflammasome
por: Cosker, Katharina, et al.
Publicado: (2021) -
The Trem2 R47H Alzheimer’s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans
por: Xiang, Xianyuan, et al.
Publicado: (2018) -
Trem2 promotes anti-inflammatory responses in microglia and is suppressed under pro-inflammatory conditions
por: Liu, Wenfei, et al.
Publicado: (2020) -
TREM2 regulates purinergic receptor-mediated calcium signaling and motility in human iPSC-derived microglia
por: Jairaman, Amit, et al.
Publicado: (2022) -
The influence of the R47H triggering receptor expressed on myeloid cells 2 variant on microglial exosome profiles
por: Mallach, Anna, et al.
Publicado: (2021)